13.07.2015 Views

DRUG REGISTRATION GUIDANCE DOCUMENT (DRGD) - BPFK

DRUG REGISTRATION GUIDANCE DOCUMENT (DRGD) - BPFK

DRUG REGISTRATION GUIDANCE DOCUMENT (DRGD) - BPFK

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Drug Registration Guidance Document (<strong>DRGD</strong>)GLOSSARYIndigenous Medicine: As defined under Regulation 2, the CDCR 1984, indigenousmedicine means a system of treatment and prevention of disease established throughtraditional use of naturally occurring substancesLicensed importer: A person to whom an import license has been issued underRegulation 12, CDCR 1984 (as defined in Regulation 2, CDCR 1984)Licensed wholesaler: A person to whom a wholesaler's licence has been issuedRegulation 12, CDCR 1984 (as defined in Regulation 2, CDCR 1984)Manufacturer: A company that carries out at least one step of production as well as thefinal release of the finished product.Manufacturing: The definition of „manufacturing‟ includes:a) The making or assembling of the product;b) The enclosing or packing of the product in any container in a form suitable foradministration or application, and the labelling of the container and;c) The carrying out of any process in the course of any of the foregoing activities.(as defined in Regulation 2, CDCR 1984)Medicinal Product: The term refers to „product‟ as stated in Regulation 2, CDCR 1984which is applicable to pharmaceutical and natural productsOTC: Refers to Generic (Non-Scheduled Poison)Product Owner: A person, company or entity who is the legal/ registered owner of theproduct formulation and/or process with whom the marketing authorization holder has acontract (glossary used in ACTD and ACTR).Product Registration Holder: The company or corporate or legal entity in the field ofpharmaceuticals whose name the marketing authorization has been granted. This partyis responsible to all aspects of the product, including quality and compliance with theconditions of marketing authorization. The authorized holder must be subjected tolegislation in the country that issued the marketing authorization, which normally meansbeing physically located in that country (glossary used in ACTD and ACTR).National Pharmaceutical Control BureauFirst Edition, January 201312

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!